Zitat von stephansdom: Bei Zitaten kann man auch den Absatz reinstellen:

Investment case summary

Formycon has a robust financial position with high revenues, cash for investment and a strong product pipeline targeting major global markets. It can now develop its own proprietary pipeline, which should add further value.

Although there are always technical risks and delays in development, these are manageable and much lower than mainstream therapeutic development. The main uncertainties are on exact product launch dates, competition and the ability of partners to market effectively in large, complex global markets. Assuming these aspects are resolved, as we expect, Formycon should become a leading and very profitable biosimilar company.

Ich finde, das trifft schon zu!
Wir werden hier noch einige Kursfeuerwerke erleben. Ohne genaue Zeitangabe , aber in den nächsten Jahren!